The effect of remote ischemic conditioning (RIC) on functional outcomes in patients with acute stroke.
Merck adds third cervical cancer nod for Keytruda, bringing total approvals to 39
Merck’s Keytruda scored its third US approval in cervical cancer, making it the first and only anti-PD-1 therapy approved as a combination with chemoradiotherapy for